Celanese Corporation (CE) Stock Analysis

Company Overview

Celanese Corporation functions as a global manufacturer and seller of engineered polymers, serving diverse industrial applications through its specialized production capabilities. The company operates within the Basic Materials sector and the Chemicals industry, positioning it as a provider of essential raw materials for downstream manufacturing processes. In terms of scale, Celanese holds a market capitalization of $7.10B and generates annual revenue of $9.54B, supported by a workforce of 11,434 employees. These financial metrics indicate that the company maintains a significant presence in the chemical supply chain, with a market cap that reflects its established role despite recent fluctuations in profitability, while its revenue base suggests substantial operational capacity across its Engineered Materials and Acetyl Chain segments.

Financial Health

The company reported total revenue of $9.54B over the trailing twelve months, yet it recorded a net income of -$1,144,000,000 and an EBITDA of $1.56B. The substantial gap between the positive EBITDA and the negative net income reveals a cost structure burdened significantly by interest expenses or other non-operating costs that eride operating profits into a net loss. Despite the net loss, the entity generated free cash flow of $368.62M, which provides a layer of financial flexibility for operational continuity and potential debt servicing even during periods of reported accounting losses. Profitability analysis shows a gross margin of 20.6%, an operating margin of 8.6%, and a profit margin of -12.2%, indicating that while the core production efficiency retains value, the final bottom line is currently negative. The balance sheet shows a cash position of $1.26B against total debt of $12.93B, resulting in a debt-to-equity ratio of 289.22, which characterizes the balance sheet as highly leveraged rather than conservative. Liquidity metrics display a current ratio of 1.55, suggesting the company holds sufficient current assets to cover short-term liabilities, though the high leverage complicates the interpretation of this safety margin. Return on Equity stands at -22.5% and Return on Assets is 2.3%, revealing that management effectiveness is currently challenged by the negative equity returns while asset utilization remains marginally positive.

Valuation Assessment

Valuation metrics include a trailing P/E Ratio of N/A and a forward P/E of 10.15, implying that the market expects future earnings to eventually become positive to justify the current stock price. The price-to-book ratio is 1.72, indicating that the stock trades at a premium of 72% over its book value, which may reflect market confidence in future recovery or asset quality despite current losses. Alternative valuation measures such as a price-to-sales ratio of 0.74 and an EV/EBITDA of 12.18 suggest the company is valued at less than one dollar of revenue, potentially offering value if operational leverage can be restored. Historical trading ranges show a 52-week high of $63.90 and a 52-week low of $35.13, placing the current valuation context within this volatility band where the stock has experienced significant price movement over the last year. The beta value is 1.05, meaning the stock exhibits slightly higher price volatility relative to the broader market, moving more than one dollar for every dollar of market movement on average.

Growth & Income

Revenue growth year-over-year stands at -6.5%, while earnings growth is N/A due to the reported net loss, indicating that the company is currently contracting in terms of top-line performance and profitability. The dividend yield is 0.2% with a payout ratio of 27.9%, suggesting that the company continues to pay a small dividend despite the net loss, which warrants scrutiny regarding the sustainability of this payout given the negative profit margin. Given the negative net income and N/A earnings growth, the company is currently unable to reinvest earnings into growth via dividends, as the payout ratio is maintained at a low level rather than reflecting strong cash generation for shareholder returns. The overall growth and income profile presents a mixed picture of a mature chemical manufacturer facing headwinds in revenue expansion while maintaining a minimal dividend commitment amidst a leveraged balance sheet and negative profitability.